Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity - PubMed (original) (raw)
Review
Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity
Géraldine Falgarone et al. Adv Cancer Res. 2009.
Abstract
For years, clusterin has been recognized as a secreted protein and a large number of works demonstrated that this ubiquitously expressed protein has multiple activities. Among the described activities several were related to inflammation and immunity such as its regulatory activity on complement. Then it became clear that a nuclear form of the protein with proapoptotic property existed and more recently that a cytoplasmic form could regulate NF-kappaB pathway. Again, these activities have a strong repercussion in inflammation and immunity. On the other hand, data available on the exact role of CLU in these processes and autoimmunity were quite scarce until recently. Indeed, in the last few years, a differential CLU expression in subtype of T cells, the regulation of CLU expression by proinflammatory cytokines and molecules, the regulation of expression and function of CLU depending on its subcellular localization, the interaction of CLU with nuclear and intracellular proteins were all reported. Adding these new roles of CLU to the already reported functions of this protein allows a better understanding of its role and potential involvement in several inflammatory and immunological processes and, in particular, autoimmunity. In this sense, rheumatoid arthritis appears to be a very attractive disease to build a new paradigm of the role and function of CLU because it makes the link between proliferation, inflammation, and autoimmunity. We will try to see in this review how to bring altogether the old and new knowledge on CLU with inflammation and autoimmunity. Nevertheless, it is clear that CLU has not yet revealed all its secrets in inflammation and autoimmunity.
Similar articles
- Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B, Orzechowski A. Pajak B, et al. Adv Cancer Res. 2009;104:33-58. doi: 10.1016/S0065-230X(09)04004-4. Adv Cancer Res. 2009. PMID: 19878772 Review. - Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses.
Cunin P, Beauvillain C, Miot C, Augusto JF, Preisser L, Blanchard S, Pignon P, Scotet M, Garo E, Fremaux I, Chevailler A, Subra JF, Blanco P, Wilson MR, Jeannin P, Delneste Y. Cunin P, et al. Cell Death Dis. 2016 May 5;7(5):e2215. doi: 10.1038/cddis.2016.113. Cell Death Dis. 2016. PMID: 27148688 Free PMC article. - The CLU-files: disentanglement of a mystery.
Rohne P, Prochnow H, Koch-Brandt C. Rohne P, et al. Biomol Concepts. 2016 Feb;7(1):1-15. doi: 10.1515/bmc-2015-0026. Biomol Concepts. 2016. PMID: 26673020 Review. - Chapter 2: Clusterin (CLU): From one gene and two transcripts to many proteins.
Rizzi F, Coletta M, Bettuzzi S. Rizzi F, et al. Adv Cancer Res. 2009;104:9-23. doi: 10.1016/S0065-230X(09)04002-0. Adv Cancer Res. 2009. PMID: 19878770 Review. - Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.
Trougakos IP, Gonos ES. Trougakos IP, et al. Adv Cancer Res. 2009;104:171-210. doi: 10.1016/S0065-230X(09)04009-3. Adv Cancer Res. 2009. PMID: 19878777 Review.
Cited by
- Protective effect of clusterin against interleukin-1β-induced apoptosis and inflammation in human knee osteoarthritis chondrocytes.
Ungsudechachai T, Jittikoon J, Honsawek S, Udomsinprasert W. Ungsudechachai T, et al. Clin Transl Sci. 2024 Jul;17(7):e13881. doi: 10.1111/cts.13881. Clin Transl Sci. 2024. PMID: 38982592 Free PMC article. - Oligomeric amyloid beta prevents myelination in a clusterin-dependent manner.
Beiter RM, Raghavan TP, Suchocki O, Ennerfelt HE, Rivet-Noor CR, Merchak AR, Phillips JL, Bathe T, Lukens JR, Prokop S, Dupree JL, Gaultier A. Beiter RM, et al. Res Sq [Preprint]. 2024 May 30:rs.3.rs-4415143. doi: 10.21203/rs.3.rs-4415143/v1. Res Sq. 2024. PMID: 38853911 Free PMC article. Preprint. - Unraveling the Intricate Web: Complement Activation Shapes the Pathogenesis of Sepsis-Induced Coagulopathy.
Wei X, Tu Y, Bu S, Guo G, Wang H, Wang Z. Wei X, et al. J Innate Immun. 2024;16(1):337-353. doi: 10.1159/000539502. Epub 2024 May 31. J Innate Immun. 2024. PMID: 38815564 Free PMC article. Review. - A novel multiplex biomarker panel for profiling human acute and chronic kidney disease.
Van Nynatten LR, Miller MR, Patel MA, Daley M, Filler G, Badrnya S, Miholits M, Webb B, McIntyre CW, Fraser DD. Van Nynatten LR, et al. Sci Rep. 2023 Dec 1;13(1):21210. doi: 10.1038/s41598-023-47418-9. Sci Rep. 2023. PMID: 38040779 Free PMC article. - Urinary SPP1 has potential as a non-invasive diagnostic marker for focal segmental glomerulosclerosis.
Ye Q, Xu G, Xue C, Pang S, Xie B, Huang G, Li H, Chen X, Yang R, Li W. Ye Q, et al. FEBS Open Bio. 2023 Nov;13(11):2061-2080. doi: 10.1002/2211-5463.13704. Epub 2023 Sep 27. FEBS Open Bio. 2023. PMID: 37696527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous